ResearcherKyungpook National UniversityNo recent work listed
Chang Min Cho
Matched on ORCID iD 0000-0002-9903-1282; OpenAlex author ID A5090411311. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 28
2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper · 2022: 3 papers
Papers 6
- The sex discrepancy effects of fruit and vegetable intake on pancreatic cancer risk; a large Korean cancer screening cohort study. Last author DOI 10.1016/j.dld.2021.07.018↗
- Prognosis and Clinical Characteristics of Patients with Pancreatic Ductal Adenocarcinoma Diagnosed by Endoscopic Ultrasonography but Indeterminate on Computed … Co-author DOI 10.5009/gnl210123↗
- Corrigendum: Prognosis and Clinical Characteristics of Patients with Pancreatic Ductal Adenocarcinoma Diagnosed by Endoscopic Ultrasonography but Indeterminate… Co-author DOI 10.5009/gnl210123.e↗
- Case Report: Development of Type 1 Autoimmune Pancreatitis in an Adolescent With Ulcerative Colitis Mimicking Pancreatic Cancer. Co-author DOI 10.3389/fped.2021.791840↗
- Inflammatory Parameters as Available Prognostic Factors for Pancreatic Cancer after Chemoradiotherapy. Co-author DOI 10.5009/gnl18113↗
- A randomized, multicenter, phase III study of gemcitabine combined with capecitabine versus gemcitabine alone as first-line chemotherapy for advanced pancreati… Co-author DOI 10.1097/md.0000000000005702↗
Closest collaborators
The 25 strongest of 28 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Sang Hyub Lee · 3 shared papers, 2017–2022 · strength 0.31
- Paper Prognosis and Clinical Characteristics of Patients with Pancreatic Ductal Adenocarcinoma Diagnosed by Endoscopic Ultras… DOI 10.5009/gnl210123↗
- Paper Corrigendum: Prognosis and Clinical Characteristics of Patients with Pancreatic Ductal Adenocarcinoma Diagnosed by Endo… DOI 10.5009/gnl210123.e↗
- Paper A randomized, multicenter, phase III study of gemcitabine combined with capecitabine versus gemcitabine alone as first-… DOI 10.1097/md.0000000000005702↗
- Tae Jun Song · 2 shared papers, 2022 · strength 0.26
- Paper Prognosis and Clinical Characteristics of Patients with Pancreatic Ductal Adenocarcinoma Diagnosed by Endoscopic Ultras… DOI 10.5009/gnl210123↗
- Paper Corrigendum: Prognosis and Clinical Characteristics of Patients with Pancreatic Ductal Adenocarcinoma Diagnosed by Endo… DOI 10.5009/gnl210123.e↗
- Seong‐Hun Kim · 2 shared papers, 2022 · strength 0.26
- Paper Prognosis and Clinical Characteristics of Patients with Pancreatic Ductal Adenocarcinoma Diagnosed by Endoscopic Ultras… DOI 10.5009/gnl210123↗
- Paper Corrigendum: Prognosis and Clinical Characteristics of Patients with Pancreatic Ductal Adenocarcinoma Diagnosed by Endo… DOI 10.5009/gnl210123.e↗
- Jun‐Ho Choi · 2 shared papers, 2022 · strength 0.26
- Paper Prognosis and Clinical Characteristics of Patients with Pancreatic Ductal Adenocarcinoma Diagnosed by Endoscopic Ultras… DOI 10.5009/gnl210123↗
- Paper Corrigendum: Prognosis and Clinical Characteristics of Patients with Pancreatic Ductal Adenocarcinoma Diagnosed by Endo… DOI 10.5009/gnl210123.e↗
- Sung Woo Ko · 2 shared papers, 2022 · strength 0.26
- Paper Prognosis and Clinical Characteristics of Patients with Pancreatic Ductal Adenocarcinoma Diagnosed by Endoscopic Ultras… DOI 10.5009/gnl210123↗
- Paper Corrigendum: Prognosis and Clinical Characteristics of Patients with Pancreatic Ductal Adenocarcinoma Diagnosed by Endo… DOI 10.5009/gnl210123.e↗
- Jai Hoon Yoon · 2 shared papers, 2022 · strength 0.26
- Paper Prognosis and Clinical Characteristics of Patients with Pancreatic Ductal Adenocarcinoma Diagnosed by Endoscopic Ultras… DOI 10.5009/gnl210123↗
- Paper Corrigendum: Prognosis and Clinical Characteristics of Patients with Pancreatic Ductal Adenocarcinoma Diagnosed by Endo… DOI 10.5009/gnl210123.e↗
- Jae Hee Cho · 2 shared papers, 2022 · strength 0.26
- Paper Prognosis and Clinical Characteristics of Patients with Pancreatic Ductal Adenocarcinoma Diagnosed by Endoscopic Ultras… DOI 10.5009/gnl210123↗
- Paper Corrigendum: Prognosis and Clinical Characteristics of Patients with Pancreatic Ductal Adenocarcinoma Diagnosed by Endo… DOI 10.5009/gnl210123.e↗
- Seung Bae Yoon · 2 shared papers, 2022 · strength 0.26
- Paper Prognosis and Clinical Characteristics of Patients with Pancreatic Ductal Adenocarcinoma Diagnosed by Endoscopic Ultras… DOI 10.5009/gnl210123↗
- Paper Corrigendum: Prognosis and Clinical Characteristics of Patients with Pancreatic Ductal Adenocarcinoma Diagnosed by Endo… DOI 10.5009/gnl210123.e↗
- Dong‐Wan Seo · 2 shared papers, 2022 · strength 0.26
- Paper Prognosis and Clinical Characteristics of Patients with Pancreatic Ductal Adenocarcinoma Diagnosed by Endoscopic Ultras… DOI 10.5009/gnl210123↗
- Paper Corrigendum: Prognosis and Clinical Characteristics of Patients with Pancreatic Ductal Adenocarcinoma Diagnosed by Endo… DOI 10.5009/gnl210123.e↗
- Hoon Jai Chun · 2 shared papers, 2022 · strength 0.26
- Paper Prognosis and Clinical Characteristics of Patients with Pancreatic Ductal Adenocarcinoma Diagnosed by Endoscopic Ultras… DOI 10.5009/gnl210123↗
- Paper Corrigendum: Prognosis and Clinical Characteristics of Patients with Pancreatic Ductal Adenocarcinoma Diagnosed by Endo… DOI 10.5009/gnl210123.e↗
- Su Youn Nam · 1 shared paper, 2022 · strength 0.22
- Sujin Choi · 1 shared paper, 2021 · strength 0.13
- Hyung Jun Kwon · 1 shared paper, 2021 · strength 0.13
- Ben Kang · 1 shared paper, 2021 · strength 0.13
- Seung Woo Park · 1 shared paper, 2017 · strength 0.05
- Si Young Song · 1 shared paper, 2017 · strength 0.05
- Hee Seung Lee · 1 shared paper, 2017 · strength 0.05
- Chang Duck Kim · 1 shared paper, 2017 · strength 0.05
- Jong Ho Moon · 1 shared paper, 2017 · strength 0.05
- Moon Jae Chung · 1 shared paper, 2017 · strength 0.05
- Dong Uk Kim · 1 shared paper, 2017 · strength 0.05
- Jeong Youp Park · 1 shared paper, 2017 · strength 0.05
- Kwang Bum Cho · 1 shared paper, 2017 · strength 0.05
- Ho Gak Kim · 1 shared paper, 2017 · strength 0.05
- Young Koog Cheon · 1 shared paper, 2017 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.